Avascular Necrosis Market Forecast 2026–2030 Presenting Long-Term Industry Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Avascular Necrosis Market Projected To Reach By 2030?

The avascular necrosis market size has experienced robust expansion in recent years. It is projected to increase from $0.89 billion in 2025 to $0.97 billion in 2026, with a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to elements such as trauma-related bone injuries, steroid overuse, alcohol consumption, delayed diagnosis, and the expansion of orthopedic surgery.

The avascular necrosis market is anticipated to experience robust expansion over the coming years. This market is projected to reach $1.38 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. The expansion during the forecast period is fueled by factors such as the increasing acceptance of advanced imaging techniques, ongoing research in regenerative medicine, an expanding aging population, the widespread occurrence of sports injuries, and continuous innovation in orthopedics. Key developments expected during this period include a heightened emphasis on early diagnostic imaging, greater uptake of therapies aimed at preserving joints, an increase in minimally invasive surgical procedures, the broadening of physical rehabilitation initiatives, and a strategic focus on intervening in the early stages of the disease.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24476&type=smp

What Major Factors Are Driving The Avascular Necrosis Market Forward?

The avascular necrosis market is anticipated to expand due to the increasing frequency of knee replacements and hip surgeries. These procedures involve surgical interventions to substitute impaired joints and alleviate discomfort in advanced stages of avascular necrosis. The rise in these surgeries stems from the rising occurrence of osteoarthritis, a condition leading to intense joint pain and restricted movement, frequently necessitating surgery for relief and better life quality. Avascular necrosis is a key factor driving the demand for knee and hip replacements, as the condition causes bone tissue to die due to insufficient blood flow, often resulting in joint damage and failure. For example, the American Joint Replacement Registry (AJRR), a US-based registry managed by the American Academy of Orthopaedic Surgeons, reported in November 2024 that hip and knee arthroplasty procedures recorded in 2023 exceeded 4 million, an 18% increase over 2022. Consequently, the increasing volume of knee and hip replacement surgeries is fueling the expansion of the avascular necrosis market.

How Is The Avascular Necrosis Market Organized By Segment Classification?

The avascular necrosis market covered in this report is segmented –

1) By Type: Trauma Related Avascular Necrosis, Non-Trauma Related Avascular Necrosis

2) By Diagnosis: Imaging, Biopsy, Computed Tomography Scan, Positron Emission Tomography, X-Ray

3) By Treatment Type: Medications, Surgery, Physical Therapy, Lifestyle Changes, Bone Grafting

4) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Trauma-Related Avascular Necrosis: Fracture-Induced Avascular Necrosis, Dislocation-Induced Avascular Necrosis, Post-Surgical Avascular Necrosis, Crush Injury-Related Avascular Necrosis, Sports Injury-Associated Avascular Necrosis

2) By Non-Trauma Related Avascular Necrosis: Steroid-Induced Avascular Necrosis, Alcohol-Induced Avascular Necrosis, Sickle Cell Disease-Associated Avascular Necrosis, Lupus-Related Avascular Necrosis, Radiation Therapy-Induced Avascular Necrosis, Idiopathic Avascular Necrosis

Who Are The Industry Participants Involved In The Avascular Necrosis Market?

Major companies operating in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc.

Get The Full Avascular Necrosis Market Report:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Which Region Is The Leading Market For The Avascular Necrosis Market?

North America was the largest region in the avascular necrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the avascular necrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Avascular Necrosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/avascular-necrosis-global-market-report

Browse Through More Reports Similar to the Global Avascular Necrosis Market 2026, By The Business Research Company

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795